Upgrades And Downgrades For Cabot Corporation (NYSE:CBT)
Recently stock market analysts have updated their consensus ratings on shares of Cabot Corporation (NYSE:CBT). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.
Most recent broker ratings
04/11/2016 – Cabot Corporation was downgraded to “sector weight” by analysts at KeyBanc.
03/14/2016 – Cabot Corporation was downgraded to “neutral” by analysts at JP Morgan. They now have a USD 47 price target on the stock.
12/09/2015 – BB&T Capital Markets began new coverage on Cabot Corporation giving the company a “buy” rating. They now have a USD 55 price target on the stock.
11/11/2015 – Cabot Corporation had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 44 price target on the stock.
11/04/2015 – Cabot Corporation had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 55 price target on the stock.
05/03/2015 – Cabot Corporation was downgraded to “sell” by analysts at Zacks.
03/16/2015 – Cabot Corporation was downgraded to “hold” by analysts at Needham & Company.
12/05/2014 – Cabot Corporation was downgraded to “neutral” by analysts at Northcoast Research.
03/10/2014 – Cabot Corporation was upgraded to “buy” by analysts at Ned Davis Research.
02/04/2014 – Cabot Corporation was upgraded to “buy” by analysts at SunTrust. They now have a USD 54 price target on the stock.
Cabot Corporation has a 50 day moving average of 48.16 and a 200 day moving average of 43.04. The stock’s market capitalization is 2.81B, it has a 52-week low of 30.70 and a 52-week high of 50.68.
The share price of the company (NYSE:CBT) was up +1.26% during the last trading session, with a high of 45.09 and the volume of Cabot Corporation shares traded was 422643.
View other investors thoughts on Cabot Corporation on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.